Market revenue in 2023 | USD 8.9 million |
Market revenue in 2030 | USD 11.1 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Dna phosphoramidites |
Fastest growing segment | RNA Phosphoramidites |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites |
Key market players worldwide | BOC Sciences, Thermo Fisher Scientific Inc, Merck KGaA, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, LGC Group, Biosynth, Bioneer, Qiagen NV, PolyOrg, Lumiprobe |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to phosphoramidite market will help companies and investors design strategic landscapes.
Dna phosphoramidites was the largest segment with a revenue share of 37.08% in 2023. Horizon Databook has segmented the Norway phosphoramidite market based on dna phosphoramidites, rna phosphoramidites, labeled phosphoramidites, modifier phosphoramidites covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway phosphoramidite market, including forecasts for subscribers. This country databook contains high-level insights into Norway phosphoramidite market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account